Maverick Capital’s Aurora Cannabis ACB Stock Holding History

Maverick Capital’s Portfolio ACB Stock Details ACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-4,486	Closed	-$55K	–	379
2022 Q3	$55K	Buy	+4,486	New	+$65.9K	﹤0.01%	343

Other funds holding ACB

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Merlin Capital Newport, Rhode Island $33.5M AUM 36.34% 1-Year Est. Return

Maverick Capital's ACB Position: Q4 2022 in Review

Maverick Capital sold out of Aurora Cannabis (ACB) in Q4 2022, closing a stake of 4,486 shares — an estimated $55K sold.

Maverick Capital first reported a position in ACB in Q3 2022 and held it in 1 quarter. The position peaked at $55K in Q3 2022. 233 funds tracked by Wall St. Rank hold ACB as of Q4 2022.

Maverick Capital reported no remaining Aurora Cannabis position as of Q4 2022 after selling out during the quarter.
Maverick Capital sold 4,486 Aurora Cannabis shares in Q4 2022, an estimated $55K.
Maverick Capital first reported a position in Aurora Cannabis in Q3 2022 and held it in 1 quarter.
Maverick Capital's Aurora Cannabis position peaked at $55K in Q3 2022.
233 funds tracked by Wall St. Rank held Aurora Cannabis as of Q4 2022.

Based on Maverick Capital's 13F filing for Q4 2022, filed 14 Feb 2023.